The Duke-Elder Undergraduate Prize Exam is a competitive exam aimed at undergraduates with an interest in ophthalmology. It is amongst the most prestigious undergraduate prizes in the United Kingdom. I would encourage motivated candidates to get their hands on as...
The authors aimed to extract statistically significant associations between non-ocular clinical and diagnostic imaging findings and the presence of significant retinal haemorrhages, and then develop an evidence-based screening algorithm to determine when to consult an ophthalmologist in suspected child abuse...
Miller Fisher syndrome (MFS) is a rare, acquired nerve disease that is considered to be a variant of Guillain-Barré syndrome. It was first recognised by James Collier in 1932 as a clinical triad of ataxia, areflexia and ophthalmoplegia. Later, it...
Irrespective of geographical location or patient cohort, emergency departments are high risk locations capable of inspiring extreme anxiety and dread in patients and doctors alike. The stress multiplies when a walk-in or referred case is suspected of underlying neurological pathology....
Neuro-ophthalmological signs (N-OS) occur commonly in children with chronic ataxia. This study describes the N-OS and their frequencies, in general and by specific disease aetiology in paediatric patients with chronic ataxia. In total, 184 patients under the age of 17...
Figure 1: Bilateral INO Introduction Complex ocular motility disorders are a diagnostic challenge. These patients come with very complex ocular motility presentations and require a careful and detailed assessment in order to find the correct diagnosis and arrange appropriate investigations....
Eye News spoke to the Ophthalmological Society of Malawi about their plans for their Congress in September, what they have learned at the RCOphth, and the impact of the Vision2020 LINKS programme.
We chat to Manoj Parulekar at the Oxford Ophthalmological Congress 2019. He tells us about the meeting, his masterclass and his highlights.
Click the image below to see his answers to our questions.